Endothelial Progenitor Cells in Sprouting Angiogenesis: Proteases Pave the Way
- PMID: 26321757
- DOI: 10.2174/1566524015666150831131214
Endothelial Progenitor Cells in Sprouting Angiogenesis: Proteases Pave the Way
Abstract
Sprouting angiogenesis consists of the expansion and remodelling of existing vessels, where the vascular sprouts connect each other to form new vascular loops. Endothelial Progenitor Cells (EPCs) are a subtype of stem cells, with high proliferative potential, able to differentiate into mature Endothelial Cells (ECs) during the neovascularization process. In addition to this direct structural role EPCs improve neovascularization, also secreting numerous pro-angiogenic factors able to enhance the proliferation, survival and function of mature ECs, and other surrounding progenitor cells. While sprouting angiogenesis by mature ECs involves resident ECs, the vasculogenic contribution of EPCs is a high hurdle race. Bone marrowmobilized EPCs have to detach from the stem cell niche, intravasate into bone marrow vessels, reach the hypoxic area or tumour site, extravasate and incorporate into the new vessel lumen, thus complementing the resident mature ECs in sprouting angiogenesis. The goal of this review is to highlight the role of the main protease systems able to control each of these steps. The pivotal protease systems here described, involved in vascular patterning in sprouting angiogenesis, are the matrix-metalloproteinases (MMPs), the serineproteinases urokinase-type plasminogen activator (uPA) associated with its receptor (uPAR) and receptorassociated plasminogen/plasmin, the neutrophil elastase and the cathepsins. Since angiogenesis plays a critical role not only in physiological but also in pathological processes, such as in tumours, controlling the contribution of EPCs to the angiogenic process, through the regulation of the protease systems involved, could yield new opportunities for the therapeutic prospect of efficient control of pathological angiogenesis.
Similar articles
-
Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: the amoeboid angiogenesis.J Exp Clin Cancer Res. 2018 Apr 3;37(1):74. doi: 10.1186/s13046-018-0742-2. J Exp Clin Cancer Res. 2018. PMID: 29615071 Free PMC article.
-
Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.Arterioscler Thromb Vasc Biol. 2001 Jul;21(7):1104-17. doi: 10.1161/hq0701.093685. Arterioscler Thromb Vasc Biol. 2001. PMID: 11451738 Review.
-
Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.J Pathol. 2001 Sep;195(2):236-43. doi: 10.1002/path.931. J Pathol. 2001. PMID: 11592104
-
The Plasminogen-Activator Plasmin System in Physiological and Pathophysiological Angiogenesis.Int J Mol Sci. 2021 Dec 29;23(1):337. doi: 10.3390/ijms23010337. Int J Mol Sci. 2021. PMID: 35008762 Free PMC article. Review.
-
Role of uPA/uPAR in the modulation of angiogenesis.Chem Immunol Allergy. 2014;99:105-22. doi: 10.1159/000353310. Epub 2013 Oct 17. Chem Immunol Allergy. 2014. PMID: 24217605 Review.
Cited by
-
Vascular therapy for Duchenne muscular dystrophy (DMD).Fac Rev. 2023 Feb 21;12:3. doi: 10.12703/r/12-3. eCollection 2023. Fac Rev. 2023. PMID: 36873982 Free PMC article. Review.
-
Inhibition of MMPs supports amoeboid angiogenesis hampering VEGF-targeted therapies via MLC and ERK 1/2 signaling.J Transl Med. 2023 Feb 9;21(1):102. doi: 10.1186/s12967-023-03954-6. J Transl Med. 2023. PMID: 36759828 Free PMC article.
-
Experimental Animal Models for Moyamoya Disease: A Species-Oriented Scoping Review.Front Surg. 2022 Jul 1;9:929871. doi: 10.3389/fsurg.2022.929871. eCollection 2022. Front Surg. 2022. PMID: 35846951 Free PMC article. Review.
-
The Potential Mechanism Behind Native and Therapeutic Collaterals in Moyamoya.Front Neurol. 2022 Apr 26;13:861184. doi: 10.3389/fneur.2022.861184. eCollection 2022. Front Neurol. 2022. PMID: 35557620 Free PMC article.
-
Characterization and functional analysis of the adipose tissue-derived stromal vascular fraction of pediatric patients with osteogenesis imperfecta.Sci Rep. 2022 Feb 14;12(1):2414. doi: 10.1038/s41598-022-06063-4. Sci Rep. 2022. PMID: 35165317 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous